Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04530383 · ClinicalTrials.gov registry record · Phase 2
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
A Phase 2 study, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT04530383 is a Phase 2 study that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT04530383, a Phase 2 study, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy of metformin to improve airway ion channel function in those with CF-related diabetes (CFRD)
Interventions
- DRUG Metformin Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2028-07-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04530383
The ClinicalTrials.gov registry entry for NCT04530383 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin Hydrochloride is the first listed.
NCT04530383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04530383 about?
NCT04530383 is a clinical study titled "Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function". The purpose of this study is to assess the efficacy of metformin to improve airway ion channel function in those with CF-related diabetes (CFRD)
What is the current status of trial NCT04530383?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2022-02-14. Estimated completion is 2028-07-15.
What interventions are being tested in trial NCT04530383?
The interventions under investigation include: Metformin Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT04530383?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.